Kotaro Nochioka1,2, Gabriela Querejeta Roca1, Brian Claggett1, Tor Biering-Sørensen1, Kunihiro Matsushita3, Chung-Lieh Hung1,4,5, Scott D Solomon1, Dalane Kitzman6, Amil M Shah1. 1. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 2. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Miyagi, Japan. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4. Department of Medicine, MacKay Medical College, Taipei, Taiwan. 5. Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan. 6. Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Abstract
Importance: Limited data exist on the prevalence and prognostic importance of right ventricular (RV) dysfunction for heart failure (HF) in the general population. Objective: To assess the prevalence of RV dysfunction and its association with HF and mortality in a community-based elderly cohort. Design, Setting, and Participants: Cross-sectional and time-to-event analysis of participants in the Atherosclerosis Risks in the Community (ARIC), a multicenter, population-based cohort study at the fifth study visit from 2011 to 2013, with a median follow-up of 4.1 years. This study included 1004 elderly participants in the ARIC study attending the fifth study visit who underwent both 3-dimensional and 2-dimensional RV echocardiography. Three-dimensional echocardiography data were analyzed between September 15, 2015, and July 24, 2016. Exposures: Right ventricular ejection fraction (RVEF), RV-pulmonary artery (PA) coupling defined by the RVEF/PA systolic pressure (PASP) ratio, and RV longitudinal strain by 3-dimensional echocardiography. Main Outcomes and Measures: For cross-sectional analysis, the prevalence of RV dysfunction across ACCF/AHA HF stages (0; A, at elevated risk for HF but without structural heart disease or clinical HF; B, structural heart disease but without clinical HF; and C, prevalent HF). For time-to-event analysis, a composite of incident HF hospitalization or all-cause death among participants free of HF at visit 5. Results: Of the 1004 participants, mean (SD) age was 76 (5) years, 385 were men (38%), and 121 were black (12%). Mean (SD) RVEF was 53% (8%). Right ventricular EF, RVEF/PASP, and RV longitudinal strain were each progressively lower across advancing HF stages. Using reference limits from stage 0 participants, RVEF was abnormal in 103 asymptomatic persons with stage A HF (15%) and 27 with stage B HF (24%). Among participants free of HF at baseline, lower RVEF and worse RV-PA coupling (ie, lower RVEF/PASP ratio) both were associated with incident HF or death independent of LVEF and N-terminal pro b-type natriuretic peptide (hazard ratio, 1.20; 95% CI, 1.02-1.42 per 5% decrease in RVEF; P = .03; hazard ratio, 1.65, 95% CI, 1.15-2.37 per 0.5 unit decrease in RVEF/PASP ratio; P = .007). Conclusions and Relevance: Right ventricular function and RV-PA coupling declined progressively across American College of Cardiology Foundation/American Heart Association HF stages. Among persons free of HF, lower RVEF was associated with incident HF or death independent of LVEF or N-terminal pro b-type natriuretic peptide.
Importance: Limited data exist on the prevalence and prognostic importance of right ventricular (RV) dysfunction for heart failure (HF) in the general population. Objective: To assess the prevalence of RV dysfunction and its association with HF and mortality in a community-based elderly cohort. Design, Setting, and Participants: Cross-sectional and time-to-event analysis of participants in the Atherosclerosis Risks in the Community (ARIC), a multicenter, population-based cohort study at the fifth study visit from 2011 to 2013, with a median follow-up of 4.1 years. This study included 1004 elderly participants in the ARIC study attending the fifth study visit who underwent both 3-dimensional and 2-dimensional RV echocardiography. Three-dimensional echocardiography data were analyzed between September 15, 2015, and July 24, 2016. Exposures: Right ventricular ejection fraction (RVEF), RV-pulmonary artery (PA) coupling defined by the RVEF/PA systolic pressure (PASP) ratio, and RV longitudinal strain by 3-dimensional echocardiography. Main Outcomes and Measures: For cross-sectional analysis, the prevalence of RV dysfunction across ACCF/AHA HF stages (0; A, at elevated risk for HF but without structural heart disease or clinical HF; B, structural heart disease but without clinical HF; and C, prevalent HF). For time-to-event analysis, a composite of incident HF hospitalization or all-cause death among participants free of HF at visit 5. Results: Of the 1004 participants, mean (SD) age was 76 (5) years, 385 were men (38%), and 121 were black (12%). Mean (SD) RVEF was 53% (8%). Right ventricular EF, RVEF/PASP, and RV longitudinal strain were each progressively lower across advancing HF stages. Using reference limits from stage 0 participants, RVEF was abnormal in 103 asymptomatic persons with stage A HF (15%) and 27 with stage B HF (24%). Among participants free of HF at baseline, lower RVEF and worse RV-PA coupling (ie, lower RVEF/PASP ratio) both were associated with incident HF or death independent of LVEF and N-terminal pro b-type natriuretic peptide (hazard ratio, 1.20; 95% CI, 1.02-1.42 per 5% decrease in RVEF; P = .03; hazard ratio, 1.65, 95% CI, 1.15-2.37 per 0.5 unit decrease in RVEF/PASP ratio; P = .007). Conclusions and Relevance: Right ventricular function and RV-PA coupling declined progressively across American College of Cardiology Foundation/American Heart Association HF stages. Among persons free of HF, lower RVEF was associated with incident HF or death independent of LVEF or N-terminal pro b-type natriuretic peptide.
Authors: Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield Journal: Circulation Date: 2014-11-12 Impact factor: 29.690
Authors: Michael H Picard; David Adams; S Michelle Bierig; John M Dent; Pamela S Douglas; Linda D Gillam; Andrew M Keller; David J Malenka; Frederick A Masoudi; Marti McCulloch; Patricia A Pellikka; Priscilla J Peters; Raymond F Stainback; G Monet Strachan; William A Zoghbi Journal: J Am Soc Echocardiogr Date: 2011-01 Impact factor: 5.251
Authors: Diego Medvedofsky; Karima Addetia; Amit R Patel; Anke Sedlmeier; Rolf Baumann; Victor Mor-Avi; Roberto M Lang Journal: J Am Soc Echocardiogr Date: 2015-08-01 Impact factor: 5.251
Authors: Heleen B van der Zwaan; Marcel L Geleijnse; Jackie S McGhie; Eric Boersma; Willem A Helbing; Folkert J Meijboom; Jolien W Roos-Hesselink Journal: Eur J Echocardiogr Date: 2011-08-02
Authors: P J Currie; J B Seward; K L Chan; D A Fyfe; D J Hagler; D D Mair; G S Reeder; R A Nishimura; A J Tajik Journal: J Am Coll Cardiol Date: 1985-10 Impact factor: 24.094
Authors: Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf Journal: J Am Coll Cardiol Date: 2011-12-06 Impact factor: 24.094
Authors: Rebecca F Gottesman; Andreea M Rawlings; A Richey Sharrett; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura H Coker; Josef Coresh; David J Couper; Michael E Griswold; Gerardo Heiss; David S Knopman; Mehul D Patel; Alan D Penman; Melinda C Power; Ola A Selnes; Andrea L C Schneider; Lynne E Wagenknecht; B Gwen Windham; Lisa M Wruck; Thomas H Mosley Journal: Am J Epidemiol Date: 2014-03-13 Impact factor: 4.897
Authors: Alexandra Gonçalves; Chung-Lieh Hung; Brian Claggett; Kotaro Nochioka; Susan Cheng; Dalane W Kitzman; Amil M Shah; Scott D Solomon Journal: Circ Cardiovasc Imaging Date: 2016-02 Impact factor: 7.792
Authors: Emily K Zern; Dongyu Wang; Paula Rambarat; Samuel Bernard; Samantha M Paniagua; Elizabeth E Liu; Jenna McNeill; Jessica K Wang; Carl T Andrews; Eugene V Pomerantsev; Michael H Picard; Jennifer E Ho Journal: Circ Heart Fail Date: 2022-02-09 Impact factor: 8.790
Authors: Akhil Vaid; Kipp W Johnson; Marcus A Badgeley; Sulaiman S Somani; Mesude Bicak; Isotta Landi; Adam Russak; Shan Zhao; Matthew A Levin; Robert S Freeman; Alexander W Charney; Atul Kukar; Bette Kim; Tatyana Danilov; Stamatios Lerakis; Edgar Argulian; Jagat Narula; Girish N Nadkarni; Benjamin S Glicksberg Journal: JACC Cardiovasc Imaging Date: 2021-10-13
Authors: Flemming Javier Olsen; Søren Zöga Diederichsen; Peter Godsk Jørgensen; Magnus T Jensen; Anders Dahl; Nino Emmanuel Landler; Claus Graff; Axel Brandes; Derk Krieger; Ketil Haugan; Lars Køber; Søren Højberg; Jesper Hastrup Svendsen; Tor Biering-Sørensen Journal: PLoS One Date: 2022-06-03 Impact factor: 3.752
Authors: Sebastian Carballo; Philippe Musso; Nicolas Garin; Hajo Müller; Jacques Serratrice; François Mach; David Carballo; Jérôme Stirnemann Journal: J Clin Med Date: 2019-10-15 Impact factor: 4.241
Authors: Antoni Bayes-Genis; Felipe Bisbal; Julio Núñez; Enrique Santas; Josep Lupón; Patrick Rossignol; Walter Paulus Journal: J Clin Med Date: 2020-04-13 Impact factor: 4.964